[1]
MuratoreM., MiglioreA., d’OnofrioF., PerriconeR., BucciR., SciosciaC., GattamelataA., SensiF., MinisolaG., VulloM.L., FamàM.I. and RavasioR. 2016. Economical Evaluation of the Sustain Program for the Out-of-Hospital Administration of Abatacept for Rheumatoid Arthritis. Global & Regional Health Technology Assessment. 3, 3 (Oct. 2016), 144-149. DOI:https://doi.org/10.33393/grhta.2016.362.